Literature DB >> 31689453

Influence of cognitive reserve in schizophrenia: A systematic review.

Paula Herrero1, Israel Contador2, Yaakov Stern3, Bernardino Fernández-Calvo4, Abraham Sánchez5, Francisco Ramos6.   

Abstract

OBJECTIVE: To perform a systematic review of the influence of sociobehavioural indicators of cognitive reserve (CR) in the risk of schizophrenia, the clinical manifestations of the disease, and cognitive intervention programs (CRT) carried out with these patients.
METHOD: A cross search was made by two independent reviewers in Pubmed and PsycINFO databases using keywords "schizophrenia" and "cognitive reserve." Twenty-one studies which analyzed different CR proxies were selected and the level of evidence was classified according to the Oxford Centre for Evidence-Based Medicine. RESULT: People with higher CR may have a lower risk of developing schizophrenia and a later onset of disease. In addition, they present better neuropsychological and functional performance in the illness course. However, the suspected influence of CR on the effectiveness of CRT in patients with schizophrenia is currently unresolved.
CONCLUSION: Our findings suggest that higher CR delays the clinical diagnosis threshold and severity of the symptoms in patients with schizophrenia. However, effect of singular sociobehavioral measures on clinical expression and benefits of intervention program need further investigation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive rehabilitation; Cognitive reserve; Schizophrenia

Year:  2019        PMID: 31689453     DOI: 10.1016/j.neubiorev.2019.10.019

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  7 in total

1.  Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study.

Authors:  Johanna Seitz-Holland; Joanne D Wojcik; Suheyla Cetin-Karayumak; Amanda E Lyall; Ofer Pasternak; Yogesh Rathi; Mark Vangel; Godfrey Pearlson; Carol Tamminga; John A Sweeney; Brett A Clementz; David A Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Sinead Kelly; Martha E Shenton; Matcheri S Keshavan; Raquelle I Mesholam-Gately; Marek Kubicki
Journal:  Mol Psychiatry       Date:  2022-08-18       Impact factor: 13.437

Review 2.  Role of Stress-Related Dopamine Transmission in Building and Maintaining a Protective Cognitive Reserve.

Authors:  Simona Cabib; Claudio Latagliata; Cristina Orsini
Journal:  Brain Sci       Date:  2022-02-11

3.  High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments.

Authors:  Arafat Hussein Al-Dujaili; Rana Fadhil Mousa; Hussein Kadhem Al-Hakeim; Michael Maes
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

4.  Premorbid Sociality Moderates Social Adjustment Change during Cognitive Enhancement Therapy for Adults with Early Schizophrenia.

Authors:  Jessica A Wojtalik; Ana T Flores; Matcheri S Keshavan; Shaun M Eack
Journal:  J Clin Child Adolesc Psychol       Date:  2022-01-19

5.  Relationship between Cognitive Reserve and Cognitive Impairment in Autonomous and Institutionalized Older Adults.

Authors:  Marina Wöbbeking-Sánchez; Beatriz Bonete-López; Antonio S Cabaco; José David Urchaga-Litago; Rosa Marina Afonso
Journal:  Int J Environ Res Public Health       Date:  2020-08-10       Impact factor: 3.390

Review 6.  Heterogeneous trajectories in schizophrenia: insights from neurodevelopment and neuroprogression models.

Authors:  Ramiro Reckziegel; Letícia S Czepielewski; Mathias Hasse-Sousa; Dayane S Martins; Maria J de Britto; Clara de O Lapa; Alexandre W Schwartzhaupt; Clarissa S Gama
Journal:  Braz J Psychiatry       Date:  2022 Jan-Feb       Impact factor: 2.697

7.  Hippocampal volume in early psychosis: a 2-year longitudinal study.

Authors:  Maureen McHugo; Kristan Armstrong; Maxwell J Roeske; Neil D Woodward; Jennifer U Blackford; Stephan Heckers
Journal:  Transl Psychiatry       Date:  2020-09-01       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.